Expression of MACC1 and c-Met in human gastric cancer and its clinical significance

Table 1 Correlation of clinicopathological parameters with MACC1 and c-Met expression in gastric cancer

Clinicopathological features	No. of cases	MACC1			c-Met
		(+)	(-)	P	(+)	(-)	P
Age(years)
<55	41	24	17	0.643	25	16	0.760
≥55	57	36	21		33	24
Gender
Male	69	42	27	0.911	41	28	0.941
Female	29	18	11		17	12
Maximal tumor size(cm)
<5	54	34	20	0.696	35	19	0.209
≥5	44	26	18		23	21
Tumor location
Cardia, fundic, body	43	30	13	0.125	29	14	0.141
Antral	55	30	25		29	26
Histology
Well differentiated	39	20	19	0.101	20	19	0.196
Poorly differentiated	59	40	19		38	21
Lymphnode metastasis
Yes	72	51	21	0.001*	47	25	0.041*
No	26	9	17		11	15
Peritoneal dissemination
Yes	26	21	5	0.017*	20	6	0.032*
No	72	39	33		38	34
Hepatic metastasis
Yes	18	15	3	0.033*	15	3	0.021*
No	80	45	35		43	37
TNM stage
I,II	43	23	20	0.165	22	21	0.153
III,IV	55	37	18		36	19
MACC1
(+)					43	17	0.002*
(-)					15	23
Odds ratio							3.878

ISSN: 1475-2867